We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Demethylation of the HACE1 gene promoter inhibits the proliferation of human liver cancer cells.
- Authors
Yu, Zhijun; Li, Yinyin; Han, Tao; Liu, Zhaozhe
- Abstract
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 (HACE1) is frequently downregulated or lost in numerous types of cancer, including liver cancer. The aim of the present study was to examine whether demethylation of the HACE1 gene could inhibit tumour progression. The expression of HACE1 was detected in liver cancer cell lines. Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated (Cas)-based demethylation single guide RNAs for the HACE1 gene promoter were designed and transfected into liver cancer cells. Subsequently, proliferation was detected by MTT and colony formation assays, and optineurin (OPTN) ubiquitination and microtubule-associated proteins 1A/1B light chain 3B protein levels were detected by immunoblotting. The levels of HACE1 were significantly reduced in liver cancer cell lines compared with in a normal liver cell line. Demethylation of the HACE1 gene promoter increased HACE1 expression, inhibited the proliferation of liver cancer cells, and promoted OPTN ubiquitination and autophagy activity in liver cancer cells. In conclusion, activation of HACE1 expression by promoter demethylation may provide a suitable approach for anticancer therapy.
- Subjects
LIVER cells; LIVER cancer; CANCER cells; DEMETHYLATION; CANCER cell proliferation; MICROTUBULE-associated proteins
- Publication
Oncology Letters, 2019, Vol 17, Issue 5, p4361
- ISSN
1792-1074
- Publication type
Article